Compare $ENSC vs $LSTA | Chartloom

Compare

$ENSC vs $LSTA

Ensysce Biosciences Inc · Lisata Therapeutics Inc

ENSC

Ensysce Biosciences Inc

LSTA

Lisata Therapeutics Inc

Compare $ENSC vs $LSTA

Comparing Ensysce Biosciences Inc and Lisata Therapeutics Inc

ENSCEnsysce Biosciences Inc

LSTALisata Therapeutics Inc

ENSCEnsysce Biosciences Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-39.3%

YTD performance

-43.9%

52W performance

-78.6%

FCF yield

-116.0%

LSTALisata Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-90.7%

YTD performance

-45.9%

52W performance

-58.1%

FCF yield

-127.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ENSC

LSTA

Detailed metrics comparison

ENSC

Ensysce Biosciences Inc

LSTA

Lisata Therapeutics Inc

Market Cap

ENSC$8M

LSTA$10M

Enterprise Value

ENSC$7M

LSTA$-786K

Price

ENSC$0.53

LSTA$1.06

P/E Ratio

ENSCN/A

LSTAN/A

P/S Ratio

ENSC1.72x

LSTA96.57x

EV/Sales

ENSC1.61x

LSTA-7.86x

EV/EBITDA

ENSC0.00x

LSTA0.00x

P/B Ratio

ENSC2.39x

LSTA1.61x

P/FCF Ratio

ENSCN/A

LSTAN/A

EV/FCF

ENSC-0.81x

LSTA0.06x

PEG Ratio

ENSCN/A

LSTAN/A

Forward P/E (NTM)

ENSCN/A

LSTAN/A

Forward P/S (NTM)

ENSCN/A

LSTAN/A

Revenue (TTM)

ENSC$5M

LSTA$100K

Revenue Growth (YoY)

ENSC-39.3%

LSTA-90.7%

Forward Rev Growth

ENSC-45.7%

LSTA44.0%

Gross Margin (TTM)

ENSC0.0%

LSTA9.5%

Operating Margin (TTM)

ENSC0.0%

LSTA0.0%

EBITDA Margin (TTM)

ENSC-197.8%

LSTA-11423.0%

Net Margin (TTM)

ENSC-280.5%

LSTA-10132.0%

FCF Margin (TTM)

ENSC-199.5%

LSTA-12323.0%

Net Income (TTM)

ENSC$-13M

LSTA$-10M

FCF (TTM)

ENSC$-9M

LSTA$-12M

EPS (TTM)

ENSC-$0.97

LSTA-$1.11

ROE (TTM)

ENSC-37496.0%

LSTA-7510.0%

ROA (TTM)

ENSC-32046.0%

LSTA-6015.0%

ROIC (TTM)

ENSC-33277.0%

LSTA-7510.0%

Cash

ENSC$677K

LSTA$10M

Debt

ENSC$197K

LSTA$0

Net Cash/Debt

ENSC$480K

LSTA$10M

Current Ratio (TTM)

ENSC0.70x

LSTA3.69x

Quick Ratio (TTM)

ENSC0.37x

LSTA3.50x

Debt/Equity (TTM)

ENSC0.10x

LSTA0.00x

Debt/Assets (TTM)

ENSC0.0%

LSTA0.0%

Interest Coverage (TTM)

ENSCN/A

LSTAN/A

Net Debt/EBITDA (TTM)

ENSC0.00x

LSTA0.00x

Beta

ENSC1.10

LSTA0.97

52W Performance

ENSC-78.6%

LSTA-58.1%

YTD Performance

ENSC-43.9%

LSTA-45.9%

% from 52W High

ENSC-80.8%

LSTA-79.1%

% from 52W Low

ENSC129.1%

LSTA7.3%

Asset Turnover (TTM)

ENSC1.14x

LSTA0.01x

FCF Yield (TTM)

ENSC-116.0%

LSTA-127.6%

Earnings Yield (TTM)

ENSC-163.1%

LSTA-104.9%

Dividend Yield (TTM)

ENSCN/A

LSTAN/A

Rule of 40

ENSC-238.8

LSTA-12,413.7

EV/GP/RG

ENSCN/A

LSTAN/A

Ticker research

View ENSC research View LSTA research

Metric	ENSC Ensysce Biosciences Inc	LSTA Lisata Therapeutics Inc
Market & Valuation
Market Cap	$8M	$10M
Enterprise Value	$7M	$-786K
Price	$0.53	$1.06
P/E Ratio	N/A	N/A
P/S Ratio	1.72x	96.57x
EV/Sales	1.61x	-7.86x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.39x	1.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.81x	0.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$100K
Revenue Growth (YoY)	-39.3%	-90.7%
Forward Rev Growth	-45.7%	44.0%
Profitability
Gross Margin (TTM)	0.0%	9.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-197.8%	-11423.0%
Net Margin (TTM)	-280.5%	-10132.0%
FCF Margin (TTM)	-199.5%	-12323.0%
Net Income (TTM)	$-13M	$-10M
FCF (TTM)	$-9M	$-12M
EPS (TTM)	-$0.97	-$1.11
ROE (TTM)	-37496.0%	-7510.0%
ROA (TTM)	-32046.0%	-6015.0%
ROIC (TTM)	-33277.0%	-7510.0%
Financial Health
Cash	$677K	$10M
Debt	$197K	$0
Net Cash/Debt	$480K	$10M
Current Ratio (TTM)	0.70x	3.69x
Quick Ratio (TTM)	0.37x	3.50x
Debt/Equity (TTM)	0.10x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.10	0.97
52W Performance	-78.6%	-58.1%
YTD Performance	-43.9%	-45.9%
% from 52W High	-80.8%	-79.1%
% from 52W Low	129.1%	7.3%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.01x
FCF Yield (TTM)	-116.0%	-127.6%
Earnings Yield (TTM)	-163.1%	-104.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-238.8	-12,413.7
EV/GP/RG	N/A	N/A
Ticker research	View ENSC research	View LSTA research

Valuation

P/S Ratio

ENSC

1.72x

LSTA

96.57x

EV/FCF

ENSC

-0.81x

LSTA

0.06x

Growth & revenue

Revenue Growth TTM

ENSC

-39.3%

LSTA

-90.7%

Forward Revenue Growth

LSTA

44.0%

ENSC

-45.7%

Profitability & performance

Gross Margin

LSTA

9.5%

ENSC

0.0%

ROE

LSTA

-7510.0%

ENSC

-37496.0%

FCF Yield %

ENSC

-116.0%

LSTA

-127.6%

52-Week Performance

LSTA

-58.1%

ENSC

-78.6%

Detailed metrics comparison

ENSC

Ensysce Biosciences Inc

LSTA

Lisata Therapeutics Inc

Market Cap

ENSC$8M

LSTA$10M

Enterprise Value

ENSC$7M

LSTA$-786K

Price

ENSC$0.53

LSTA$1.06

P/E Ratio

ENSCN/A

LSTAN/A

P/S Ratio

ENSC1.72x

LSTA96.57x

EV/Sales

ENSC1.61x

LSTA-7.86x

EV/EBITDA

ENSC0.00x

LSTA0.00x

P/B Ratio

ENSC2.39x

LSTA1.61x

P/FCF Ratio

ENSCN/A

LSTAN/A

EV/FCF

ENSC-0.81x

LSTA0.06x

PEG Ratio

ENSCN/A

LSTAN/A

Forward P/E (NTM)

ENSCN/A

LSTAN/A

Forward P/S (NTM)

ENSCN/A

LSTAN/A

Revenue (TTM)

ENSC$5M

LSTA$100K

Revenue Growth (YoY)

ENSC-39.3%

LSTA-90.7%

Forward Rev Growth

ENSC-45.7%

LSTA44.0%

Gross Margin (TTM)

ENSC0.0%

LSTA9.5%

Operating Margin (TTM)

ENSC0.0%

LSTA0.0%

EBITDA Margin (TTM)

ENSC-197.8%

LSTA-11423.0%

Net Margin (TTM)

ENSC-280.5%

LSTA-10132.0%

FCF Margin (TTM)

ENSC-199.5%

LSTA-12323.0%

Net Income (TTM)

ENSC$-13M

LSTA$-10M

FCF (TTM)

ENSC$-9M

LSTA$-12M

EPS (TTM)

ENSC-$0.97

LSTA-$1.11

ROE (TTM)

ENSC-37496.0%

LSTA-7510.0%

ROA (TTM)

ENSC-32046.0%

LSTA-6015.0%

ROIC (TTM)

ENSC-33277.0%

LSTA-7510.0%

Cash

ENSC$677K

LSTA$10M

Debt

ENSC$197K

LSTA$0

Net Cash/Debt

ENSC$480K

LSTA$10M

Current Ratio (TTM)

ENSC0.70x

LSTA3.69x

Quick Ratio (TTM)

ENSC0.37x

LSTA3.50x

Debt/Equity (TTM)

ENSC0.10x

LSTA0.00x

Debt/Assets (TTM)

ENSC0.0%

LSTA0.0%

Interest Coverage (TTM)

ENSCN/A

LSTAN/A

Net Debt/EBITDA (TTM)

ENSC0.00x

LSTA0.00x

Beta

ENSC1.10

LSTA0.97

52W Performance

ENSC-78.6%

LSTA-58.1%

YTD Performance

ENSC-43.9%

LSTA-45.9%

% from 52W High

ENSC-80.8%

LSTA-79.1%

% from 52W Low

ENSC129.1%

LSTA7.3%

Asset Turnover (TTM)

ENSC1.14x

LSTA0.01x

FCF Yield (TTM)

ENSC-116.0%

LSTA-127.6%

Earnings Yield (TTM)

ENSC-163.1%

LSTA-104.9%

Dividend Yield (TTM)

ENSCN/A

LSTAN/A

Rule of 40

ENSC-238.8

LSTA-12,413.7

EV/GP/RG

ENSCN/A

LSTAN/A

Ticker research

View ENSC research View LSTA research

Metric	ENSC Ensysce Biosciences Inc	LSTA Lisata Therapeutics Inc
Market & Valuation
Market Cap	$8M	$10M
Enterprise Value	$7M	$-786K
Price	$0.53	$1.06
P/E Ratio	N/A	N/A
P/S Ratio	1.72x	96.57x
EV/Sales	1.61x	-7.86x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.39x	1.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.81x	0.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$100K
Revenue Growth (YoY)	-39.3%	-90.7%
Forward Rev Growth	-45.7%	44.0%
Profitability
Gross Margin (TTM)	0.0%	9.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-197.8%	-11423.0%
Net Margin (TTM)	-280.5%	-10132.0%
FCF Margin (TTM)	-199.5%	-12323.0%
Net Income (TTM)	$-13M	$-10M
FCF (TTM)	$-9M	$-12M
EPS (TTM)	-$0.97	-$1.11
ROE (TTM)	-37496.0%	-7510.0%
ROA (TTM)	-32046.0%	-6015.0%
ROIC (TTM)	-33277.0%	-7510.0%
Financial Health
Cash	$677K	$10M
Debt	$197K	$0
Net Cash/Debt	$480K	$10M
Current Ratio (TTM)	0.70x	3.69x
Quick Ratio (TTM)	0.37x	3.50x
Debt/Equity (TTM)	0.10x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.10	0.97
52W Performance	-78.6%	-58.1%
YTD Performance	-43.9%	-45.9%
% from 52W High	-80.8%	-79.1%
% from 52W Low	129.1%	7.3%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.01x
FCF Yield (TTM)	-116.0%	-127.6%
Earnings Yield (TTM)	-163.1%	-104.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-238.8	-12,413.7
EV/GP/RG	N/A	N/A
Ticker research	View ENSC research	View LSTA research